BrainStorm Cell Therapeutics
BCLI
#10451
Rank
โ‚ฌ8.23 M
Marketcap
0,75ย โ‚ฌ
Share price
-9.47%
Change (1 day)
-33.34%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): -1,32ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,29ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,86ย โ‚ฌ an increase over its 2014 EPS that were of -8,85ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,32ย โ‚ฌ
2015-5,86ย โ‚ฌ-33.82%
2014-8,85ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
7,66ย โ‚ฌ-692.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,95ย โ‚ฌ-559.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,48ย โ‚ฌ 169.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,67ย โ‚ฌ 338.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,70ย โ‚ฌ 108.72%๐Ÿ‡บ๐Ÿ‡ธ USA